statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	339
IT - Italia	168
VN - Vietnam	168
SG - Singapore	139
CN - Cina	100
HK - Hong Kong	64
NL - Olanda	40
BD - Bangladesh	31
IE - Irlanda	19
SE - Svezia	18
KR - Corea	17
BR - Brasile	16
FR - Francia	16
DE - Germania	14
AT - Austria	13
IN - India	11
CH - Svizzera	10
JP - Giappone	9
PH - Filippine	8
TH - Thailandia	8
ZA - Sudafrica	8
GB - Regno Unito	7
CA - Canada	6
FI - Finlandia	6
ID - Indonesia	6
MX - Messico	6
PK - Pakistan	5
TG - Togo	5
TR - Turchia	5
CI - Costa d'Avorio	4
RU - Federazione Russa	4
TW - Taiwan	4
IQ - Iraq	3
PL - Polonia	3
BE - Belgio	2
CL - Cile	2
CR - Costa Rica	2
EC - Ecuador	2
NG - Nigeria	2
PT - Portogallo	2
UA - Ucraina	2
VE - Venezuela	2
AL - Albania	1
AR - Argentina	1
BG - Bulgaria	1
CM - Camerun	1
CO - Colombia	1
CY - Cipro	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
ES - Italia	1
ET - Etiopia	1
HN - Honduras	1
IL - Israele	1
IS - Islanda	1
JM - Giamaica	1
LU - Lussemburgo	1
PY - Paraguay	1
SC - Seychelles	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
Totale	1.317

Nome	#
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs	237
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma	236
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis	161
Outcome of hepatic resection for HCC in ideal and non-ideal candidates	158
Etiology of Hepatocellular Carcinoma May Influence the Pattern of Progression under Atezolizumab-Bevacizumab	106
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors	102
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive care	90
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study	88
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma	84
Statins and clinical outcomes in patients with advanced hepatocellular carcinoma treated with Atezolizumab plus Bevacizumab	51
Surveillance for Hepatocellular Carcinoma in Patients with Successfully Treated Viral Disease of the Liver: A Systematic Review	36
Primary biliary cholangitis: current insights and novel therapies	12
Totale	1.361

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	0	0	0	0	10	1	7	21	3
2022/2023	66	2	7	2	2	7	3	16	2	10	1	7	7
2023/2024	35	1	3	1	3	3	4	2	11	2	2	0	3
2024/2025	170	7	10	13	9	7	9	27	6	7	33	16	26
2025/2026	1.009	58	42	58	62	71	36	158	66	233	100	44	81
2026/2027	39	39	0	0	0	0	0	0	0	0	0	0	0
Totale													1.361

CRIS Current Research Information System